Even with more restrictive assumptions, the analysis still showed a substantial treatment gap, with only 14.2% of patients ...

In this week’s edition of The Prototype, we look at quantum computing for image recognition, a gene therapy using a patient’s ...

Less than 7% of people with severe drug-resistant infections in low- and middle-income countries are receiving the ...

"At some point it might not be beneficial anymore to stick around with your buddies. But if you don't, you die." ...

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have ...

Colistin is a polymyxin antibiotic used as a last-resort treatment for severe infections caused by multidrug-resistant Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa. Due ...